These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2000787)

  • 1. Usefulness of blood lactate as a predictor of shock development in acute myocardial infarction.
    Mavrić Z; Zaputović L; Zagar D; Matana A; Smokvina D
    Am J Cardiol; 1991 Mar; 67(7):565-8. PubMed ID: 2000787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood lactate is a predictor of short-term mortality in patients with myocardial infarction complicated by heart failure but without cardiogenic shock.
    Gjesdal G; Braun OÖ; Smith JG; Scherstén F; Tydén P
    BMC Cardiovasc Disord; 2018 Jan; 18(1):8. PubMed ID: 29347907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiogenic shock developing in the coronary care unit in patients with ST-elevation myocardial infarction.
    De Luca G; Savonitto S; Greco C; Parodi G; Dajelli Ermolli NC; Silva C; Lucci D; Gonzini L; Maggioni AP; Cuccia C;
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1023-9. PubMed ID: 18799965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The value of shock index in prediction of cardiogenic shock developed during primary percutaneous coronary intervention.
    Wei Z; Bai J; Dai Q; Wu H; Qiao S; Xu B; Wang L
    BMC Cardiovasc Disord; 2018 Oct; 18(1):188. PubMed ID: 30285644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cardiogenic shock in acute myocardial infarct].
    Pongrac B; Vincelj J; Biocić S; Vesković M; Kirin M
    Lijec Vjesn; 1995 Jun; 117 Suppl 2():40-2. PubMed ID: 8649150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality after emergent percutaneous coronary intervention in cardiogenic shock secondary to acute myocardial infarction and usefulness of a mortality prediction model.
    Klein LW; Shaw RE; Krone RJ; Brindis RG; Anderson HV; Block PC; McKay CR; Hewitt K; Weintraub WS;
    Am J Cardiol; 2005 Jul; 96(1):35-41. PubMed ID: 15979429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth-differentiation factor 15 and osteoprotegerin in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the IABP-SHOCK II-trial.
    Fuernau G; Poenisch C; Eitel I; de Waha S; Desch S; Schuler G; Adams V; Werdan K; Zeymer U; Thiele H
    Eur J Heart Fail; 2014 Aug; 16(8):880-7. PubMed ID: 24903195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma concentrations of interleukin-6, organ failure, vasopressor support, and successful coronary revascularization in predicting 30-day mortality of patients with cardiogenic shock complicating acute myocardial infarction.
    Geppert A; Dorninger A; Delle-Karth G; Zorn G; Heinz G; Huber K
    Crit Care Med; 2006 Aug; 34(8):2035-42. PubMed ID: 16775569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic impact of established and novel renal function biomarkers in myocardial infarction with cardiogenic shock: A biomarker substudy of the IABP-SHOCK II-trial.
    Fuernau G; Poenisch C; Eitel I; Denks D; de Waha S; Pöss J; Heine GH; Desch S; Schuler G; Adams V; Werdan K; Zeymer U; Thiele H
    Int J Cardiol; 2015 Jul; 191():159-66. PubMed ID: 25965624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intraaortic balloon counterpulsation and microcirculation in cardiogenic shock complicating myocardial infarction: an IABP-SHOCK II substudy.
    Jung C; Fuernau G; de Waha S; Eitel I; Desch S; Schuler G; Figulla HR; Thiele H
    Clin Res Cardiol; 2015 Aug; 104(8):679-87. PubMed ID: 25720332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strong-ion gap approach in patients with cardiogenic shock following ST-elevation myocardial infarction.
    Attanà P; Lazzeri C; Chiostri M; Picariello C; Gensini GF; Valente S
    Acute Card Care; 2013 Sep; 15(3):58-62. PubMed ID: 23806089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of in-hospital mortality after percutaneous coronary intervention for cardiogenic shock.
    Valente S; Lazzeri C; Vecchio S; Giglioli C; Margheri M; Bernardo P; Comeglio M; Chiocchini S; Gensini GF
    Int J Cardiol; 2007 Jan; 114(2):176-82. PubMed ID: 16737749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prasugrel vs clopidogrel in cardiogenic shock patients undergoing primary PCI for acute myocardial infarction. Results of the ISAR-SHOCK registry.
    Orban M; Mayer K; Morath T; Bernlochner I; Hadamitzky M; Braun S; Schulz S; Hoppmann P; Hausleiter J; Tiroch K; Mehilli J; Schunkert H; Massberg S; Laugwitz KL; Sibbing D; Kastrati A
    Thromb Haemost; 2014 Dec; 112(6):1190-7. PubMed ID: 25183544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distortion of the terminal portion of the QRS is predictor of shock after primary percutaneous coronary intervention for acute myocardial infarction.
    Garcia-Rubira JC; Garcia-Borbolla R; Nuñez-Gil I; Manzano MC; Garcia-Romero MM; Fernandez-Ortiz A; Perez de Isla L; Macaya C
    Int J Cardiol; 2008 Nov; 130(2):241-5. PubMed ID: 18068246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Blood lactic acid, blood pyruvate and lactate excess in patients with acute myocardial infarct].
    Ferro L; Meaney E; Calva E; Malpartida F; Froufe J; Cárdenas M
    Arch Inst Cardiol Mex; 1973; 43(5):757-65. PubMed ID: 4761966
    [No Abstract]   [Full Text] [Related]  

  • 16. Baseline serum bicarbonate levels independently predict short-term mortality in critically ill patients with ischaemic cardiogenic shock.
    Wigger O; Bloechlinger S; Berger D; Häner J; Zanchin T; Windecker S; Räber L; Schefold JC
    Eur Heart J Acute Cardiovasc Care; 2018 Feb; 7(1):45-52. PubMed ID: 28838261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibroblast growth factor 23 in acute myocardial infarction complicated by cardiogenic shock: a biomarker substudy of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial.
    Fuernau G; Pöss J; Denks D; Desch S; Heine GH; Eitel I; Seiler S; de Waha S; Ewen S; Link A; Schuler G; Adams V; Böhm M; Thiele H
    Crit Care; 2014 Dec; 18(6):713. PubMed ID: 25528363
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Temporal Trends in Predictors of Early and Late Mortality After Emergency Coronary Artery Bypass Grafting for Cardiogenic Shock Complicating Acute Myocardial Infarction.
    Davierwala PM; Leontyev S; Verevkin A; Rastan AJ; Mohr M; Bakhtiary F; Misfeld M; Mohr FW
    Circulation; 2016 Oct; 134(17):1224-1237. PubMed ID: 27777292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute hyperglycaemia and inflammation in patients with ST segment elevation myocardial infarction.
    Terlecki M; Bednarek A; Kawecka-Jaszcz K; Czarnecka D; Bryniarski L
    Kardiol Pol; 2013; 71(3):260-7. PubMed ID: 23575781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A simple risk chart for initial risk assessment of 30-day mortality in patients with cardiogenic shock from ST-elevation myocardial infarction.
    Cheng JM; Helming AM; van Vark LC; Kardys I; Den Uil CA; Jewbali LS; van Geuns RJ; Zijlstra F; van Domburg RT; Boersma E; Akkerhuis KM
    Eur Heart J Acute Cardiovasc Care; 2016 Apr; 5(2):101-7. PubMed ID: 25589634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.